Dasappa V, Ross W B, King J, King D W, Clingan P R, Morris D L
Department of Surgery, The St. George Hospital, Kogarah, Sydney, Australia.
Int J Colorectal Dis. 1996;11(1):38-41. doi: 10.1007/BF00418854.
Twenty-two patients with colorectal cancer and synchronous unresectable hepatic metastases were treated by resection the primary tumour with concurrent insertion of an Infusaid infusaport system for regional chemoperfusion (hepatic arterial 20, portal venous 2). Four patients in addition had cryotherapy the liver metastases. Morbidity from the synchronous procedures was minimal. Median survival was 10 months. Four patients with poorly-differentiated tumours had a poor response, with a median survival of 3.75 months.
22例患有结直肠癌并伴有同步不可切除肝转移的患者接受了原发肿瘤切除,并同时植入Infusaid输注端口系统进行区域化疗灌注(肝动脉20例,门静脉2例)。另外4例患者对肝转移灶进行了冷冻治疗。同步手术的并发症发生率极低。中位生存期为10个月。4例肿瘤分化差的患者反应不佳,中位生存期为3.75个月。